Work

Upadacitinib in Mothers With Inflammatory Bowel Disease: Placental Transfer and Breast Milk Excretion

Year: 2025

Type: article

Abstract: sponsorship: This study was supported by unrestricted grants from the Novo Nordisk Foundation (grant no. NNF23OC0081717) and the Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. The external funder had no involvement in any aspect of the study or writing of the report. (Novo Nordisk Foundation|NNF23OC0081717, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium)

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2025.06.007

Authors: Dana Duricova, Elena Sonnenberg, Patrick Augustijns, Katarina Mitrova, Philip O. Anderson, Barbora Pipek, Raf Mols, Kristyna Zdychyncova, Kristyna Kubickova, Milan Lukas, Mette Mejlby Hansen, Lise Svenningsen, Jeremiah Momper, Mette Julsgaard

Institutions: Charles University, Institute of Clinical and Experimental Medicine, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, KU Leuven, Iscare I.V.F, University of California San Diego, Aarhus University, Aarhus University Hospital, Aalborg University

Language: English

Topic: Pregnancy and Medication Impact

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,470

Funders: AbbVie, Aarhus Universitet, Aarhus Universitetshospital, KU Leuven, Novo Nordisk, Novo Nordisk Fonden, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences

OpenAlex ID: W4411589993

FWCI: 4.247

Cites: 7

Cited by: 5

Related to: 10